PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-66.33%
Negative net income growth while AVGO stands at 9.66%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-3.06%
Negative yoy D&A while AVGO is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-160.50%
Negative yoy deferred tax while AVGO stands at 4912.50%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
182.05%
SBC growth while AVGO is negative at -6.67%. John Neff would see competitor possibly controlling share issuance more tightly.
2892.00%
Well above AVGO's 102.60% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
2016.67%
AR growth well above AVGO's 80.36%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
145.95%
Inventory shrinking or stable vs. AVGO's 1000.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
277.60%
AP growth well above AVGO's 144.44%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-43.16%
Both reduce yoy usage, with AVGO at -625.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-1044.00%
Both negative yoy, with AVGO at -13266.67%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-9.73%
Negative yoy CFO while AVGO is 67.97%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
36.00%
Some CapEx rise while AVGO is negative at -12.31%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
55.46%
Purchases growth of 55.46% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
194.30%
Liquidation growth of 194.30% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
86.88%
We have mild expansions while AVGO is negative at -10.45%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment similar to AVGO's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
111.11%
Stock issuance far above AVGO's 166.67%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.